Searchable abstracts of presentations at key conferences in endocrinology

ea0035p258 | Clinical case reports Pituitary/Adrenal | ECE2014

Different courses of Carpenter syndrome

Matyjaszek-Matuszek Beata , Lenart-Lipinska Monika , Rudzki Grzegorz , Tarach Jerzy

Introduction: Autoimmune polyglandular syndrome type 2 (APS type 2) is co-occurrence of primary adrenal insufficiency (Addison disease) and autoimmune thyroid disease – most commonly Hashimoto thyroiditis (Schmidt syndrome). If it is associated with type 1 diabetes mellitus it is known as Carpenter syndrome. We present clinical pictures of two 33-year-old patients (born in 1980) diagnosed with APS type 2 manifested as Carpenter syndrome to emphasize different courses of t...

ea0090p87 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

IADPSG Vs Carpenter and Coustan Criteria for the Diagnosis of Gestational Diabetes Mellitus in a Spanish Population: Is it Worth Switching?

Martin Borge Virginia , Mira Sharona Azriel , Garcia-Riano Garcia Taida , Rubio Valtuena Jose , Garcia Romero de Tejada Gema , Antonio Balsa Rubio Jose

Objective: The aim of this study was to evaluate maternal and perinatal outcomes before and after implementation of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria for testing of gestational diabetes mellitus (GDM).Methods: This is a retrospective cohort study of women with GDM followed at a single university hospital. We compared maternal and neonatal outcomes of singleton pregnancies in women with GMD before (from...

ea0009p106 | Endocrine tumours and neoplasia | BES2005

Selective parathyroid venous sampling in patients with complicated primary hyperparathyroidism

Ogilvie C , Brown P , Matson M , Carpenter R , Drake W , Jenkins P , Chew S , Monson J

Selective Parathyroid Venous Sampling in Patients with Complicated Primary HyperparathyroidismCM Ogilvie, PL Brown, M Matson, R Carpenter, WM Drake, PJ Jenkins, SL Chew, JP MonsonCentre for Endocrinology and Departments of Surgery and Radiology, St Bartholomew's Hospital, QMUL, London EC1A 7BEThe role of pre-operative localisation of abnormal parathyroid glands remains controversial but is particularly releva...

ea0034s4.3 | Putting flesh on the bones | SFEBES2014

Management of hypophosphatemic rickets

Carpenter Thomas

Hypophosphatemia due to excess urinary phosphate losses and rachitic bone disease occur in several related disorders. The most common form of the heritable hypophosphatemic disorders, X-linked hypophosphatemia (XLH, estimated incidence: 1/10 000–1/20 000), is due to loss-of-function mutations of the osteocyte/osteoblast protein, PHEX. Associated elevations in circulating FGF23 lead to reduced abundance of phosphate transporters on the luminal surface of renal tubular cell...

ea0025sig1.2 | Bone and mineral special interest group | SFEBES2011

Patients teaching doctors: hypophosphatemic rickets and the revelation of a novel phosphate homeostatic system

Carpenter Thomas

Familial hypophosphatemic rickets was recognized in the 1950s, when hypophosphatemia due to renal phosphate wasting was identified in individuals with rickets unresponsive to vitamin D therapy. X-linked dominant inheritance was evident in many cases, and the most common form of the disease is known as X-linked hypophosphatemia (XLH). A description of vitamin D-refractory rickets likely represents the first report of XLH (Albright F et al., Am J Dis Children 1937)...

ea0011p106 | Clinical case reports | ECE2006

Parathyroid carcinoma in multiple endocrine neoplasia (MEN) type 1: two case reports

Agha A , Carpenter R , Bhattacharya S , Monson JP

Hyperparathyroidism occurs in most patients with MEN Type 1 but the association of MEN type-1 with parathyroid carcinoma has only been described previously in one patient. In this report, we describe two further cases of parathyroid carcinoma presenting in association of MEN type 1 syndrome.The first patient was a 69-year-old woman who presented with severe hyperparathyroidism and tracheal compression by a mediastinal mass which was shown histologically ...

ea0055we14 | Workshop E: Disorders of the adrenal gland | SFEEU2018

Hyporeninaemic hypoaldosteronism in surgically cured Conn’s syndrome

Pittaway James , Coppack Simon , Carpenter Rob , Drake William

A 53 year old gentleman from Ghana was referred to our clinic for further management of his Conn’s syndrome. This had been diagnosed at another hospital 3 years previously when he presented with hypertension and hypokalaemia on the back of 14 years of poorly controlled hypertension. Serum aldosterone was raised at 3178 pmol/l and serum renin mass was 3.9 mU/l. MRI revealed a 5 mm nodule in the medial limb of the right adrenal gland. He was initially commenced on medical t...

ea0015p80 | Clinical practice/governance and case reports | SFEBES2008

An unusually large thyroglossal cyst harbouring a papillary thyroid cancer

Parvanta Laila , Berney Dan , Richards Polly , Akker Scott , Carpenter Robert

A 24-year-old girl was referred with a massive thyroglossal duct cyst (TGDC) and an intra-cystic papillary thyroid cancer (PTC). The impressive clinical photographs, striking radiological images and histology slides are presented.She presented eight and half months post partum with a 10 cm midline neck lump of 4 years duration. She was asymptomatic and was on levothyroxine for Hashimoto’s thyroiditis.Clinically, there was a cy...

ea0011p92 | Clinical case reports | ECE2006

Purely adrenaline-secreting phaeochromocytoma: a classical presentation of a rare entity

Merghani A , Darzy KH , Morris D , Carpenter R , Deaner A , Monson JP

A provisional diagnosis of paroxysmal atrial fibrillation with normal blood pressure and echocardiogram was made in a 58 years old man. He described ‘funny turns’ on standing during which he would become sweaty, tremulous with palpitations and headache and facial flushing preceded by pallor. The patient was otherwise fit and healthy with a BMI of 27.3 kg/m2; he used to drink about 15 pints of beer per week and smoke 11 cigarettes daily for the last 40 year...

ea0009p94 | Endocrine tumours and neoplasia | BES2005

Development of a tamoxifen resistant breast cancer cell line

McVittie C , Khalaf S , Bustin S , Carpenter R , Jenkins P

Background: Tamoxifen is a partial estrogen agonist used to treat estrogen receptor positive breast cancer. It has been discovered however that resistance to tamoxifen develops in some cancers. In order to investigate the mechanisms underlying the development of resistance we have created a tamoxifen resistant breast cancer cell line.Aims: To develop a breast cancer cell line that is resistant to the anti-growth effects of tamoxifen.<p class="abstext...